SalaryGuide
AboutPricingFor Employers

Marketing jobs

4 marketing jobs

Werfen logo
9 days ago

Senior Product Manager, Hemostasis On-Market Reagents

Werfen

Bedford, MA (Unknown)Full time$150K/yr – $180K/yr
Werfen logo
5 weeks ago

WW Marketing Communications Manager

Werfen

Bedford, MA (Hybrid)Full time$100K/yr – $130K/yr
Werfen logo
4 months ago

WW Marketing Director

Werfen

San Diego, CA (On-site)Full time$210K/yr – $250K/yr
Werfen logo
8 months ago

Senior Product Manager, Hemostasis Reagents

Werfen

Bedford, MA (On-site)Full time$150K/yr – $180K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

4 jobs
Werfen logo

Senior Product Manager, Hemostasis On-Market Reagents

Werfen

Bedford, MA (Unknown)

$150K/yr - $180K/yrIn-houseFull-timeSenior level5+ years exp.
9 days ago
Werfen logo

WW Marketing Communications Manager

Werfen

Bedford, MA (Hybrid)

$100K/yr - $130K/yrIn-houseFull-timeMid level5+ years exp.
5 weeks ago
Werfen logo

WW Marketing Director

Werfen

San Diego, CA (On-site)

$210K/yr - $250K/yrIn-houseFull-timeDirector/executive10+ years exp.
4 months ago
Werfen logo

Senior Product Manager, Hemostasis Reagents

Werfen

Bedford, MA (On-site)

$150K/yr - $180K/yrIn-houseFull-timeSenior level3+ years exp.
8 months ago
Werfen logo
Werfen

Senior Product Manager, Hemostasis On-Market Reagents

Bedford, MA (Unknown)

$150K/yr – $180K/yrSenior Level5+ years expFull time

Posted 9 days ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own and drive the on-market hemostasis reagent portfolio end-to-end, shaping strategy, launches, and lifecycle while collaborating cross-functionally.

  • Define positioning, pricing, and market segmentation
  • Lead global launches and portfolio reviews

Job Description

Responsibilities

  • Manage the end-to-end lifecycle of the on-market reagent portfolio, driving product performance, sustainment, and obsolescence planning through end-of-life
  • Analyze market trends, customer needs, competitive dynamics, and emerging technologies to inform portfolio and product strategies.
  • Develop product positioning, value propositions, pricing strategies, and market segmentation plans.
  • Lead global launch planning and execution for new hemostasis reagents.
  • Monitor product performance and implement strategies to achieve revenue, market share, and profitability objectives.
  • Support key customer engagements, advisory boards, scientific meetings, and industry conferences.
  • Collaborate with R&D, Clinical Affairs, Regulatory Affairs, Quality, Operations, and Technical Services to support product development and sustainment activities.
  • Contribute to business planning, forecasting, and strategic portfolio reviews.
  • Drive resolution of product-related issues and proactively manage multiple projects simultaneously.
  • Serve as the market, customer, and business expert for the hemostasis reagent portfolio.

Requirements

  • Bachelor's degree in Business Administration or marketing discipline, or equivalent.
  • Prior experience in marketing product management positions.
  • Minimum five years of experience in sales and three years in marketing.
  • International Mobility: Required: No
  • Travel Requirements: Some travel required

Benefits

  • This role is eligible for medical, dental, and vision insurance, 401k plan retirement benefits with an employer match, as well as paid vacation and sick leave.
  • Our sales roles are eligible for participation in a commission plan and our management, and select professional roles, are eligible for a performance-based bonus.
Werfen logo

Werfen

Werfen is a growing, family-owned, innovative company founded in 1966 in Barcelona, Spain.We are a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant.We operate directly in 30 countries, and in more than 100 territories through distributors. Our headquarters are in Barcelona, Spain and our Technology Centers are located in the United States and Europe. Worldwide sales in 2024 were almost € 2.2 billion and our workforce is 7,000 strong.

Founded in 1966
L'Hospitalet de Llobregat, Catalonia, ESP
6.5K employees (167 in marketing)
www.werfen.com

Traffic Signals

Monthly Visitors
147.5K
Monthly Google Ads Budget
$300
Traffic Source Mix
Search
48.9%
Direct
41.9%
Referral
7.2%
Social
1.3%
Paid
0.6%

Headcount Trend

Current headcount: ~6.5K

Marketing Team

Marketing Team Size
150 (2% of company)
Marketing Roles Posted (Last 30 Days)
3

Recent News

Volition, Werfen Sign Licensing, Commercialization Deal for Antiphospholipid Syndrome Test
Sep 9, 2025 • GenomeWeb
Autoimmunity Diagnostics Market worth US$8.98 billion by 2031 with 8.3% CAGR | MarketsandMarkets™
Aug 7, 2025 • PR Newswire UK
Autoimmunity Diagnostics Market worth US$8.98 billion by 2031 with 8.3% CAGR | MarketsandMarkets™
Aug 7, 2025 • PR Newswire
D-dimer Testing Market Size to Hit USD 2.74 Billion by 2032, Fueled by Rising Incidence of Thrombotic Disorders and Aging Population | SNS Insider
Aug 5, 2025 • SNS Insider pvt ltd
Seegene Previews Modular End-to-End PCR Automation System at ADLM
Aug 1, 2025 • GenomeWeb
AWARD-WINNING GEM® PREMIER™ 7000 with iQM®3 EXPANDS COMMERCIALIZATION TO EUROPE
Jul 29, 2025 • PR Newswire
ADLM announces 2025 Top Corporate Supporter Award recipients and thanks them for their vital backing
Jul 29, 2025 • PR Newswire
AWARD-WINNING GEM® PREMIER™ 7000 with iQM®3 EXPANDS COMMERCIALIZATION TO EUROPE
Jul 29, 2025 • Morningstar.com
Els germans Rubiralta (Werfen) lideren les inversions familiars en capital risc
Jul 25, 2025 • El Nacional.cat
Global Fibrinogen Testing Market Analysis and Forecast to 2032 by Product, Technology, Grade, Application, End-user and Region
Jun 27, 2025 • Research and Markets
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
Jun 23, 2025 • Exagen Inc.
HLA Typing Market Global Forecasts to 2030: Diagnostic Applications Dominate HLA Market with Focus on Infectious Disease Testing
Jun 12, 2025 • Research and Markets
Coagulation Analyzer Market worth US$5,335.9 million by 2030 with 7.2% CAGR | MarketsandMarkets™
Jun 4, 2025 • PR Newswire
Coagulation Analyzer Market worth US$5,335.9 million by 2030 with 7.2% CAGR | MarketsandMarkets™
Jun 4, 2025 • PR Newswire UK
HSBC Continental Europe: Pre Stabilisation Notice
Jun 3, 2025 • HSBC Continental Europe
Transplant Diagnostics Market: Improving Healthcare Infra...
May 26, 2025 • PharmiWeb
Point of Care Diagnostics Market worth $68.5 billion by 2030 - Exclusive Report by The Research Insights
May 14, 2025 • PR Newswire
Point of Care Diagnostics Market worth $68.5 billion by 2030 - Exclusive Report by The Research Insights
May 14, 2025 • PR Newswire UK
WERFEN WINS EDISON AWARD FOR GEM® PREMIER™ 7000 WITH IQM®3 BLOOD GAS TESTING SYSTEM
May 1, 2025 • PR Newswire
Werfen assoleix 170 milions de benefici amb les seves solucions de diagnòstic clínic
Apr 8, 2025 • thenewbarcelonapost.cat
WERFEN COMMERCIALIZES ACL TOP® FAMILY 70 SERIES HEMOSTASIS TESTING SYSTEMS IN NORTH AMERICA
Mar 31, 2025 • PR Newswire
Alejandro Risso substituirà Carlos Pascual i serà el nou CEO de Werfen
Dec 6, 2024 • VIA Empresa
Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative
Oct 8, 2024 • Canadian News Wire
Werfen Receives CE Mark for Aptiva® Antiphospholipid Syndrome Reagents
Feb 19, 2024 • PR Newswire
Werfen launches We Venture Capital to invest in disruptive technologies that will shape the future of diagnostics
Sep 7, 2023 • capital-riesgo.es
Seegene and Werfen Partner to Collaborate on OneSystem™ Business to Develop Syndromic qPCR Assays
Jun 14, 2023 • PRNewswire
Werfen Announces CE Mark for Aptiva CTD Essential Reagent
Dec 2, 2021 • BioSpace
Werfen increases sales by over 13% and reaffirms its global leadership in in vitro diagnostics
Apr 26, 2018 • werfen.com
Werfen Increases Sales by Over 13% and Reaffirms Its Global Leadership in In Vitro Diagnostics
Apr 26, 2018 • PRNewswire UK